Biotage AB and McMaster University Sign Two Year Extension To Molecular Imaging Development Agreement
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: McMaster University has successfully completed the first year research agreement, with a key journal publication and several technical presentations. “We used the Biotage Initiator™ Microwave synthesis system, chromatography cartridges to prepare a range of Carborane Cage structures labeled with rhenium and technetium (Tc99c), the currently most used radionuclide in diagnostic medicine. We reported an 85% reduction in synthesis time and 26% gain in decay corrected yield, when compared to the traditional synthesis methods. The speed, purity and flexibility of this approach will drive the development of a new generation of novel molecular imaging agents.” Dr. John F. Valliant, Associate Professor of Chemistry and Medical Physics and Acting Director of McMaster Institute of Applied Radiation Sciences (McIARS) stated.